Cytori Reports Second Quarter 2017 Business And Financial Results

SAN DIEGO, Aug. 10, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ:CYTX) (“Cytori” or the “Company”) today announced its second quarter 2017 financial results and provided updates on its corporate activity and clinical development.

Second quarter 2017 net loss was $6.0 million, or $0.19 per share. Operating cash burn for the quarter was approximately $5.0 million. Cytori ended the quarter with approximately $9.0 million of cash and cash equivalents.

Back to news